Literature DB >> 31885214

DOCK5 regulates energy balance and hepatic insulin sensitivity by targeting mTORC1 signaling.

Yerui Lai1, Anjiang Zhao2, Minghong Tan1, Mengliu Yang1,3, Yao Lin2, Shengbing Li1, Jinlin Song4, Hongting Zheng5, Zhiming Zhu6, Dongfang Liu1, Chaohong Liu7, Ling Li1, Gangyi Yang1.   

Abstract

The dedicator of cytokinesis 5 (DOCK5) is associated with obesity. However, the mechanism by which DOCK5 contributes to obesity remains completely unknown. Here, we show that hepatic DOCK5 expression significantly decreases at a state of insulin resistance (IR). Deletion of DOCK5 in mice reduces energy expenditure, promotes obesity, augments IR, dysregulates glucose metabolism, and activates the mTOR (Raptor)/S6K1 pathway under a high-fat diet (HFD). The overexpression of DOCK5 in hepatocytes inhibits gluconeogenic gene expression and increases the level of insulin receptor (InsR) and Akt phosphorylation. DOCK5 overexpression also inhibits mTOR/S6K1 phosphorylation and decreases the level of raptor protein expression. The opposite effects were observed in DOCK5-deficient hepatocytes. Importantly, in liver-specific Raptor knockout mice and associated hepatocytes, the effects of an adeno-associated virus (AAV8)- or adenovirus-mediated DOCK5 knockdown on glucose metabolism and insulin signaling are largely eliminated. Additionally, DOCK5-Raptor interaction is indispensable for the DOCK5-mediated regulation of hepatic glucose production (HGP). Therefore, DOCK5 acts as a regulator of Raptor to control hepatic insulin activity and glucose homeostasis.
© 2019 The Authors.

Entities:  

Keywords:  DOCK5; glucose metabolism; insulin resistance; mTOR pathway

Mesh:

Substances:

Year:  2019        PMID: 31885214      PMCID: PMC7001503          DOI: 10.15252/embr.201949473

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  51 in total

1.  Identification of an evolutionarily conserved superfamily of DOCK180-related proteins with guanine nucleotide exchange activity.

Authors:  Jean-François Côté; Kristiina Vuori
Journal:  J Cell Sci       Date:  2002-12-15       Impact factor: 5.285

2.  Active Rac1 improves pathologic VEGF neovessel architecture and reduces vascular leak: mechanistic similarities with angiopoietin-1.

Authors:  Mien V Hoang; Janice A Nagy; Donald R Senger
Journal:  Blood       Date:  2010-10-28       Impact factor: 22.113

Review 3.  TOR signaling in growth and metabolism.

Authors:  Stephan Wullschleger; Robbie Loewith; Michael N Hall
Journal:  Cell       Date:  2006-02-10       Impact factor: 41.582

4.  Novel association approach for variable number tandem repeats (VNTRs) identifies DOCK5 as a susceptibility gene for severe obesity.

Authors:  Julia S El-Sayed Moustafa; Hariklia Eleftherohorinou; Adam J de Smith; Johanna C Andersson-Assarsson; Alexessander Couto Alves; Eleni Hadjigeorgiou; Robin G Walters; Julian E Asher; Leonardo Bottolo; Jessica L Buxton; Rob Sladek; David Meyre; Christian Dina; Sophie Visvikis-Siest; Peter Jacobson; Lars Sjöström; Lena M S Carlsson; Andrew Walley; Mario Falchi; Philippe Froguel; Alexandra I F Blakemore; Lachlan J M Coin
Journal:  Hum Mol Genet       Date:  2012-05-16       Impact factor: 6.150

5.  Overexpression of juxtaposed with another zinc finger gene 1 reduces proinflammatory cytokine release via inhibition of stress-activated protein kinases and nuclear factor-κB.

Authors:  Mengliu Yang; Jihuan Dai; Yanjun Jia; Langquzhen Suo; Shengbing Li; Yunsong Guo; Hua Liu; Ling Li; Gangyi Yang
Journal:  FEBS J       Date:  2014-06-17       Impact factor: 5.542

6.  Chronic inhibition of the mTORC1/S6K1 pathway increases insulin-induced PI3K activity but inhibits Akt2 and glucose transport stimulation in 3T3-L1 adipocytes.

Authors:  Alain Veilleux; Vanessa P Houde; Kerstin Bellmann; André Marette
Journal:  Mol Endocrinol       Date:  2010-03-04

7.  The adipose triglyceride lipase, adiponectin and visfatin are downregulated by tumor necrosis factor-alpha (TNF-alpha) in vivo.

Authors:  Ling Li; Gangyi Yang; Shaochuan Shi; Mengliu Yang; Hua Liu; Guenther Boden
Journal:  Cytokine       Date:  2008-11-20       Impact factor: 3.861

8.  Hepatic SIRT1 attenuates hepatic steatosis and controls energy balance in mice by inducing fibroblast growth factor 21.

Authors:  Yu Li; Kimberly Wong; Amber Giles; Jianwei Jiang; Jong Woo Lee; Andrew C Adams; Alexei Kharitonenkov; Qin Yang; Bin Gao; Leonard Guarente; Mengwei Zang
Journal:  Gastroenterology       Date:  2013-11-01       Impact factor: 22.682

9.  USP9X deubiquitylating enzyme maintains RAPTOR protein levels, mTORC1 signalling and proliferation in neural progenitors.

Authors:  Caitlin R Bridges; Men-Chee Tan; Susitha Premarathne; Devathri Nanayakkara; Bernadette Bellette; Dusan Zencak; Deepti Domingo; Jozef Gecz; Mariyam Murtaza; Lachlan A Jolly; Stephen A Wood
Journal:  Sci Rep       Date:  2017-03-24       Impact factor: 4.379

10.  The focal adhesion-associated proteins DOCK5 and GIT2 comprise a rheostat in control of epithelial invasion.

Authors:  S R Frank; C P Köllmann; J F van Lidth de Jeude; J R Thiagarajah; L H Engelholm; M Frödin; S H Hansen
Journal:  Oncogene       Date:  2016-09-26       Impact factor: 9.867

View more
  4 in total

Review 1.  Signaling pathways in obesity: mechanisms and therapeutic interventions.

Authors:  Xue Wen; Bohan Zhang; Beiyi Wu; Haitao Xiao; Zehua Li; Ruoyu Li; Xuewen Xu; Tao Li
Journal:  Signal Transduct Target Ther       Date:  2022-08-28

2.  Physical Activity Rewires the Human Brain against Neurodegeneration.

Authors:  Jose A Santiago; James P Quinn; Judith A Potashkin
Journal:  Int J Mol Sci       Date:  2022-06-02       Impact factor: 6.208

3.  FGF21 facilitates autophagy in prostate cancer cells by inhibiting the PI3K-Akt-mTOR signaling pathway.

Authors:  Han Dai; Wenjing Hu; Lianying Zhang; Feiyu Jiang; Xiongmin Mao; Gangyi Yang; Ling Li
Journal:  Cell Death Dis       Date:  2021-03-22       Impact factor: 8.469

Review 4.  RHO to the DOCK for GDP disembarking: Structural insights into the DOCK GTPase nucleotide exchange factors.

Authors:  Andrew P Thompson; Christina Bitsina; Janine L Gray; Frank von Delft; Paul E Brennan
Journal:  J Biol Chem       Date:  2021-03-05       Impact factor: 5.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.